Jonathan E. Schneeweis

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

2

Total Citations

671

H-Index

2

About

Jonathan E. Schneeweis is a pioneering chemist whose work bridges the gap between automation and molecular synthesis. His most impactful contribution, the 2014 paper "Nanomole-scale high-throughput chemistry for the synthesis of complex molecules" (647 citations), revolutionized drug discovery by miniaturizing and automating synthetic route scouting. This breakthrough allows researchers to screen thousands of reaction conditions using vanishingly small quantities of precious materials—a game-changer for natural product synthesis and pharmaceutical development where timelines are tight and materials scarce. Earlier, Schneeweis developed fluorogenic substrates for measuring endothelial lipase (EL) activity (2006, 24 citations), creating critical tools for discovering small molecule inhibitors targeting HDL cholesterol regulation. His work exemplifies how clever assay design can unlock therapeutic targets. Schneeweis’s legacy lies in transforming synthetic chemistry from a labor-intensive, gram-scale endeavor into a high-throughput, nanomole-scale discipline—democratizing access to complex molecule synthesis and accelerating the pace of drug discovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
671
Total Citations
336
Avg Citations/Paper
🏆 Most Cited Paper
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
647 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago